Fibronectin is a 420 kilodalton glycoprotein, comprising two similar subunits. It is present as a soluble dimer in plasma (circulating fibronectin) and as an insoluble multimer in the basement membrane and intercellular matrix (cellular fibronectin).' 2 Fibronectin is present in virtually all body tissues and fluids and is involved in adhesion, spreading, and phagocytosis.34 Decreased fibronectin concentrations have been shown in patients after burns, trauma, or sepsis.f7 We have recently shown a significant decrease in circulating fibronectin concentrations in patients with AIDS and AIDS-related complex (ARC). 8 Fibronectin concentrations were noticeably decreased in patients with Pneumocystis carinii pneumonitis. Some investigators have observed that human cerebrospinal fluid contains fibronectin that is immunologically indistinguishable from the circulating form. 9 Weller et al' showed increased cerebrospinal fluid fibronectin concentrations in patients with bacterial meningitis and with tick-borne encephalitis. More recently, we observed decreased cerebrospinal fluid fibronectin concentrations in patients with aseptic meningitis. 1 l
The measurement of fibronectin could be of some diagnostic and prognostic value in several disorders of the central nervous system and in particular in HIV-1 infected patients with neurological complications. Although fibronectin cannot be considered an acute phase protein, its determination in the cerebrospinal fluid could be of some help in the diagnosis and prognosis of central nervous system disorders in HIV-1 infected patients.
Methods
The study population comprised 41 HIV-1 infected patients with central nervous system disorders: five HIV-1 asymptomatic seropositive patients with cognitive changes and abnormalities on cerebral tomography scanning (mean (SD) age 29-8 (5d1) years); 14 patients with AIDS dementia complex (mean age 28-9 (3-9) years); four patients with suspected progressive multifocal leucoencephalopathy (mean age 28-5 (3-5) years); and 18 patients with other opportunistic infections, of whom 11 had cerebral toxoplasmosis (mean age 28x5 (3 5) years), two patients had mycobacterial meningitis caused by Mycobacterium avium-intracellulare (mean age 30 5 (2 1) years), and five had cryptococcal meningitis (mean age 35-8 (17-3) years).
Central nervous system disorders were diagnosed on various clinical, radiological, and laboratory grounds. Asymptomatic HIV-1 seropositive patients were included, and lumbar puncture was performed on admission, as they had minor behavioral and cognitive changes, together with initial signs of cerebral atrophy detected by cerebral tomography scanning. In particular, diagnosis of AIDS dementia complex was based on persistent cognitive impairment, impaired motor performance, behavioral changes, and radiological abnormalities, including progressive, severe cerebral atrophy and abnormalities of white matter or basal ganglia or thalamus. Diagnosis of progressive multifocal leucoencephalopathy was based on clinical and radiological findings. Magnetic resonance imaging scans showed large lesions of white matter, adjacent to the cortex, without enhancement, and unaccompanied by mass patients had central nervous system opportunistic infections, and cerebral toxoplasmosis was the most common infection. All patients were drug misusers except for two who were homosexual. Table 2 shows the fibronectin concentrations in the cerebrospinal fluid of patients with AIDS and central nervous system disorders. A significant decrease in fibronectin concentrations was observed in patients with progressive multifocal leucoencephalopathy and in those with AIDS dementia complex (p < 0.0001). In patients with central nervous system opportunistic infections cerebrospinal fluid fibronectin concentrations were significantly decreased as well. Table 3 shows the cerebrospinal fluid fibronectin concentrations in patients with fungal or mycobacterial infections. Decreased fibronectin concentrations were noted in patients with cerebral toxoplasmosis and cryptococcal meningitis (p < 0.0001). A smaller decrease in cerebrospinal fluid fibronectin concentrations was observed in patients with mycobacterial meningitis.
Discussion
There was a substantial decrease in fibronectin concentrations in the cerebrospinal fluid of patients with AIDS dementia complex and less noticeable decreases in patients with opportunistic infections and progressive multifocal leucoencephalopathy. Amsterdam, 1992) . The significant decrease in cerebrospinal fibronectin concentrations in patients with AIDS dementia complex or with progressive multifocal leucoencephalopathy could be related to the ability of fibronectin to bind to HIV itself or to viral proteins. In the same way, binding of fibronectin to Toxoplasma gondii, Cryptococcus neoformans, or Mycobacterium species could increase consumption of fibronectin in the cerebrospinal fluid of patients with opportunistic infections.
As accumulation of neutrophils in patients with viral or cryptococcal, mycobacterial, and toxoplasma meningitis is rarely observed, de novo synthesis of fibronectin by neutrophils does not seem to be likely in these conditions. Thus the consumption of fibronectin caused by binding to viral, fungal, or protozoal organisms may exceed intrathecal production due to the reaction of the tissue damaged by these agents.
